
Sign up to save your podcasts
Or
Bad trips, anti-drug PSAs, and the crackdown under the Controlled Substances Act of 1970 helped stigmatize psychedelics in the U.S. But now, there’s renewed clinical inquiry into whether these drugs can ease emotional trauma. To understand the future of psychedelics, Audie calls up Ernesto Londoño, reporter at the New York Times and author of the new book, “Trippy: The Peril and Promise of Medicinal Psychedelics.” They discuss his own mental health and psychedelic journeys and why he thinks there’s good reason for both hope and skepticism.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
4.6
918918 ratings
Bad trips, anti-drug PSAs, and the crackdown under the Controlled Substances Act of 1970 helped stigmatize psychedelics in the U.S. But now, there’s renewed clinical inquiry into whether these drugs can ease emotional trauma. To understand the future of psychedelics, Audie calls up Ernesto Londoño, reporter at the New York Times and author of the new book, “Trippy: The Peril and Promise of Medicinal Psychedelics.” They discuss his own mental health and psychedelic journeys and why he thinks there’s good reason for both hope and skepticism.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
37,886 Listeners
1,167 Listeners
3,834 Listeners
1,690 Listeners
6,666 Listeners
4,848 Listeners
4,632 Listeners
110,802 Listeners
388 Listeners
303 Listeners
1,313 Listeners
2,391 Listeners
5,410 Listeners
139 Listeners
8,212 Listeners
332 Listeners
124 Listeners
179 Listeners
148 Listeners
460 Listeners
344 Listeners
1,481 Listeners
3,311 Listeners
84 Listeners
310 Listeners
162 Listeners
32 Listeners
60 Listeners
1,538 Listeners
12 Listeners
63 Listeners
5 Listeners